MicroIslet Announces Voluntary Reorganization Filing
November 10, 2008 17:57 ET
|
MicroIslet, Inc.
SAN DIEGO, Nov. 10, 2008 (GLOBE NEWSWIRE) -- MicroIslet Inc. (OTCBB:MIIS) (http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for...
MicroIslet Completes a $1 Million Private Placement
November 16, 2007 08:30 ET
|
MicroIslet, Inc.
SAN DIEGO, Nov. 16, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) is a biotechnology company engaged in the development and commercialization of encapsulated islet cells for transplantation...
MicroIslet Announces the Appointment of Amaresh Basu, Ph.D. as Vice President, Research and Development, and the Retention of Regulus Pharmaceutical Consulting
October 15, 2007 09:00 ET
|
MicroIslet, Inc.
SAN DIEGO, Oct. 15, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) announced today that Amaresh Basu, Ph.D. has been named Vice President, Research and Development. Separately, MicroIslet...
Barry Ritholtz, Noted Stock Market Analyst, Appointed to the Board of Directors of MicroIslet
September 26, 2007 08:35 ET
|
MicroIslet, Inc.
SAN DIEGO, Sept. 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Barry Ritholtz has been named to the Company's Board of Directors.
"I am very excited...
MicroIslet Receives $1 Million Working Capital Loan
September 21, 2007 09:30 ET
|
MicroIslet, Inc.
SAN DIEGO, Sept. 21, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS), a development-stage biotechnology company with patented and proprietary technologies focused on transplantation therapy for...
MicroIslet and Progenitor Cell Therapy Enter Into Agreement for the Manufacturing of MicroIslet-P, an Encapsulated Islet Cell Product for the Treatment of Type 1 Diabetes
September 17, 2007 10:05 ET
|
MicroIslet, Inc.
SAN DIEGO and HACKENSACK, N.J., Sept. 17, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS), a development-stage biotechnology company with patented and proprietary technologies focused on...
MicroIslet, Inc. Files Quarterly Report On Form 10-QSB for Second Quarter 2007
August 21, 2007 09:30 ET
|
MicroIslet, Inc.
SAN DIEGO, Aug. 21, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) announced that it filed its Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007, with the Securities and...
MicroIslet Implements Staffing Changes to Further the Company's New Corporate Strategy
July 23, 2007 09:00 ET
|
MicroIslet, Inc.
SAN DIEGO, July 23, 2007 (PRIME NEWSWIRE) -- As previously announced, MicroIslet, Inc. (OTCBB:MIIS) (the "Company") has refocused its efforts to accelerate the clinical testing of the Company's...
Jonathan Lakey, Co-Developer of the Edmonton Protocol, Named President, and Michael J. Andrews Appointed Chief Executive Officer of MicroIslet
July 05, 2007 14:40 ET
|
MicroIslet, Inc.
SAN DIEGO, July 5, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R.T. Lakey, Ph.D., M.S.M., has been named as President of MicroIslet, and...
Edmonton Protocol Diabetes Islet Cell Pioneer Named Chief Scientific Officer of MicroIslet
June 26, 2007 12:34 ET
|
MicroIslet, Inc.
SAN DIEGO, June 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R. T. Lakey, Ph.D., M.S.M., was named the Company's Chief Scientific Officer...